The 0.1 mg/mL atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.

Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.

Both preservative-free, contact lens-friendly drops will be available in most national retailers.

IVMED-85 is a preservative-free, nonatropine daily drop that slows myopia progression by strengthening scleral and corneal collagen crosslinks via LOX activation.

This strategic investment will allow both companies to better serve the Canadian market.

Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.

Diane Russo, OD, MPH, MBA, FAAO, Dipl AAO PH, and Nicole Quinn, OD, FAAO, highlight the continued importance of residencies in optometric practices.

The PDUFA date for Brimochol PF is January 28, 2026.

Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.

Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.

At the Collaborative Care Symposium, Rachelle Lin, OD, MS, FAAO, highlighted how newer retinal therapies are addressing treatment gaps by offering extended dosing intervals without compromising efficacy—ultimately easing the burden on both patients and providers.

Increases in the doses of atropine were most common following the pandemic and especially among patients for whom therapy was initiated with the 0.01% dose.

The qVPT, a suprathreshold test comprised of 15 trials at 9 cycles per degree and 20% contrast, measures the patient’s response time to visual stimuli and the number of correct responses.

A recent US Court of International Trade decision was made on May 28 to permanently prohibit all tariffs imposed by President Donald J. Trump under the International Emergency Economic Powers Act.

Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.